386898005: Nevirapine (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Transferase inhibitor\Reverse transcriptase inhibitor\Nevirapine (substance)
\Substance categorized by disposition\Substance with antiviral mechanism of action (substance)\Substance with antiretroviral mechanism of action (substance)\Reverse transcriptase inhibitor\Nevirapine (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Substance with antiviral mechanism of action (substance)\Substance with antiretroviral mechanism of action (substance)\Reverse transcriptase inhibitor\Nevirapine (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\...

\Organic cyclic compound\Substance with cyclopropane structure (substance)\Nevirapine (substance)
\Organic cyclic compound\Heterocyclic compound\Nevirapine (substance)

\Hydrocarbon\Alkane\Cyclic alkane\Substance with cyclopropane structure (substance)\Nevirapine (substance)

\Substance categorised by physical state\Gaseous substance\Alkane\Cyclic alkane\Substance with cyclopropane structure (substance)\Nevirapine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Nevirapine (substance)	Is a	Reverse transcriptase inhibitor	true	Inferred relationship	Some
Nevirapine (substance)	Is a	classe d'allergènes	false	Inferred relationship	Some
Nevirapine (substance)	Is a	allergène médicamenteux	false	Inferred relationship	Some
Nevirapine (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Reverse transcriptase inhibitor (disposition)	true	Inferred relationship	Some
Nevirapine (substance)	Is a	produit chimique catégorisé selon sa fonction	false	Inferred relationship	Some
Nevirapine (substance)	Is a	Heterocyclic compound	true	Inferred relationship	Some
Nevirapine (substance)	Is a	Transferase inhibitor	false	Inferred relationship	Some
Nevirapine (substance)	Is a	Substance with cyclopropane structure (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing nevirapine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Nevirapine (substance)	Inferred relationship	Some	1
Nevirapine 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nevirapine (substance)	Inferred relationship	Some
Product containing precisely nevirapine (as nevirapine hemihydrate) 10 milligram/1 milliliter conventional release oral suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nevirapine (substance)	Inferred relationship	Some
Product containing lamivudine and nevirapine and zidovudine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Nevirapine (substance)	Inferred relationship	Some	2
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nevirapine (substance)	Inferred relationship	Some
Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nevirapine (substance)	Inferred relationship	Some
Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nevirapine (substance)	Inferred relationship	Some
Product containing lamivudine and nevirapine and stavudine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Nevirapine (substance)	Inferred relationship	Some	3
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nevirapine (substance)	Inferred relationship	Some
Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nevirapine (substance)	Inferred relationship	Some
Nevirapine 400 mg prolonged-release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nevirapine (substance)	Inferred relationship	Some
Allergy to nevirapine	Causative agent (attribute)	True	Nevirapine (substance)	Inferred relationship	Some	1
Product containing nevirapine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Nevirapine (substance)	Inferred relationship	Some	1
Lamivudine- and nevirapine- and stavudine-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Nevirapine (substance)	Inferred relationship	Some	3
Lamivudine- and nevirapine- and zidovudine-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Nevirapine (substance)	Inferred relationship	Some	2
Nevirapine hemihydrate (substance)	Is a	False	Nevirapine (substance)	Inferred relationship	Some
Nevirapine 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nevirapine (substance)	Inferred relationship	Some	1
Nevirapine 200 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Nevirapine (substance)	Inferred relationship	Some	1
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nevirapine (substance)	Inferred relationship	Some	2
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Nevirapine (substance)	Inferred relationship	Some	2
Nevirapine 400 mg prolonged-release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Nevirapine (substance)	Inferred relationship	Some	1
Nevirapine 400 mg prolonged-release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Nevirapine (substance)	Inferred relationship	Some	1
Nevirapine 200 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Nevirapine (substance)	Inferred relationship	Some	1
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Nevirapine (substance)	Inferred relationship	Some	2
Product containing precisely nevirapine (as nevirapine hemihydrate) 10 milligram/1 milliliter conventional release oral suspension	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Nevirapine (substance)	Inferred relationship	Some	1
Nevirapine hemihydrate (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Nevirapine (substance)	Inferred relationship	Some
Lamivudine and nevirapine and stavudine only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Nevirapine (substance)	Inferred relationship	Some	3
Lamivudine and nevirapine and zidovudine only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Nevirapine (substance)	Inferred relationship	Some	2
Product containing only nevirapine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Nevirapine (substance)	Inferred relationship	Some	1
Product containing only lamivudine and nevirapine and zidovudine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Nevirapine (substance)	Inferred relationship	Some	2
Product containing only lamivudine and nevirapine and stavudine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Nevirapine (substance)	Inferred relationship	Some	3
Product containing only nevirapine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Nevirapine (substance)	Inferred relationship	Some	1
Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Nevirapine (substance)	Inferred relationship	Some	3
Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Nevirapine (substance)	Inferred relationship	Some	3
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Nevirapine (substance)	Inferred relationship	Some	3
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Nevirapine (substance)	Inferred relationship	Some	3
Lamivudine and nevirapine and stavudine only product in oromucosal dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Nevirapine (substance)	Inferred relationship	Some	3
Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Nevirapine (substance)	Inferred relationship	Some	3
Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Nevirapine (substance)	Inferred relationship	Some	3
Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Nevirapine (substance)	Inferred relationship	Some	3
Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Nevirapine (substance)	Inferred relationship	Some	3
Product containing lamivudine and nevirapine and stavudine in oromucosal dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Nevirapine (substance)	Inferred relationship	Some	3
Nevirapine 50 mg prolonged-release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Nevirapine (substance)	Inferred relationship	Some	1
Nevirapine 50 mg prolonged-release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Nevirapine (substance)	Inferred relationship	Some	1
Product containing precisely nevirapine 10 milligram/1 milliliter conventional release oral suspension (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Nevirapine (substance)	Inferred relationship	Some	1
Product containing precisely nevirapine 10 milligram/1 milliliter conventional release oral suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Nevirapine (substance)	Inferred relationship	Some	1
Product containing precisely nevirapine 100 milligram/1 each prolonged-release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Nevirapine (substance)	Inferred relationship	Some	1
Product containing precisely nevirapine 100 milligram/1 each prolonged-release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Nevirapine (substance)	Inferred relationship	Some	1
Product containing precisely nevirapine 50 milligram/1 each tablet for conventional release oral suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Nevirapine (substance)	Inferred relationship	Some	1
Product containing precisely nevirapine 50 milligram/1 each tablet for conventional release oral suspension (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Nevirapine (substance)	Inferred relationship	Some	1
Nevirapine anhydrous (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Nevirapine (substance)	Inferred relationship	Some

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461076017	Nevirapine (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481012015	Nevirapine	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
56711000195111	nevirapina	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
827671000172115	névirapine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
71741000195117	Nevirapin	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module